MEDS

Q: What is the price of Trxade Group (MEDS) today?

The price of Trxade Group (MEDS) today is US$ 0,00, with a variation of 0% compared to the last year. The price of Trxade Group (MEDS) started the year trading around US$ 0,00 and today it is at US$ 0,00. Follow the real-time price chart, the historical price of Trxade Group (MEDS), and stock data from Ibovespa and international markets.

Q: When does Trxade Group (MEDS) pay dividends?

Trxade Group (MEDS) não distribuiu dividendos no último ano.

Q: Trxade Group (MEDS) is it worth it?

Currently, Trxade Group (MEDS) is priced at US$ 0,00, with a P/E of 0,46%, representing a deviation of 0,09% from its historical average P/E. In the last year, the stock showed a variation of 0% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 125,16%. The total shareholder return was 0,00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Trxade Group (MEDS)?

Investing in stocks of Trxade Group (MEDS) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Trxade Group (MEDS) yield today?

The yield of Trxade Group (MEDS) was 0,00% in the last month, 0,00% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 125,16%.If you wanted to buy 100 stocks of Trxade Group (MEDS) today, the total investment would be US$ 0,00, based on the current price of US$ 0,00.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 0,00In 5 years: US$ 0,00In 10 years: 0,00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Trxade Group Inc.

This asset is no longer available for investment.

View all assets

Price

US$ -

variation (12m)

0,00%

p/l

0,46

p/vp

0,64

DIVIDEND YIELD

125,16%

price MEDS

BVMF

MEDS

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of MEDS

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

0,00%

3 months

0,00%

1 year

0,00%

2 years

0,00%

5 years

0,00%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

0,00%

3 months

0,00%

1 year

0,00%

2 years

0,00%

5 years

0,00%

10 years

0,00%

Indicators MEDS

check out the fundamentals of Trxade Group shares

P/E

0,46

Sector: 4,73 Industry: 9,71

P/SALES RATIO (PSR)

1,84

Sector: 0,72 Industry: 1,50

P/BV

0,64

Sector: 0,99 Industry: 2,72

DIVIDEND YIELD (DY)

125,16%

Sector: 0,10% Industry: 0,01%

ROA

111,40%

Sector: -3,62% Industry: 3,48%

ROE

140,31%

Sector: -6,47% Industry: 7,46%

ROIC

-67,67%

Sector: -20,20% Industry: -5,56%

NET MARGIN

100,00%

Sector: -5,85% Industry: 1,71%

GROSS MARGIN

82,43%

Sector: 32,53% Industry: 25,06%

OPERATING MARGIN

-100,00%

Sector: -3,74% Industry: 0,51%

P/EBITDA

-0,84

Sector: 2,78 Industry: 2,63

P/EBIT

-0,80

Sector: 1,45 Industry: 0,24

P/ASSET

0,51

Sector: 0,49 Industry: 1,29

BVPS

11,79

Sector: 6,14 Industry: 15,34

EPS

16,54

Sector: -0,37 Industry: 1,51

EQUITY / ASSETS

0,79

Sector: 0,38 Industry: 0,47

CAGR REVENUES 5 YEARS

-24,73%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

0,00%

Sector: - Industry: -

FAIR PRICE OF Trxade Group ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 0,00

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

MEDS indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
HOG	13,74	0,96	6,99%	2,73%	US$ 3,18 B	5,00%
DPZ	23,77	-3,48	-14,62%	1,66%	US$ 13,82 B	11,99%
EBAY	19,20	8,83	45,99%	1,25%	US$ 41,93 B	20,86%
WEN	8,49	14,81	174,46%	8,96%	US$ 1,67 B	8,87%
LEG	7,90	1,38	17,50%	2,35%	US$ 1,18 B	3,57%
DHI	12,44	1,87	15,06%	1,06%	US$ 46,08 B	10,96%
TXRH	22,57	7,35	32,58%	1,62%	US$ 10,78 B	8,08%
CBRL	15,91	1,86	11,72%	2,56%	US$ 860,58 M	1,56%
LEN	14,43	1,34	9,26%	1,68%	US$ 30,41 B	6,49%
CAAS	4,27	0,33	7,65%	0,00%	US$ 134,30 M	4,44%
SWBI	26,17	1,19	4,56%	5,26%	US$ 434,72 M	3,44%
DASH	125,06	12,66	10,13%	0,00%	US$ 113,06 B	7,25%
GT	2,80	0,37	13,20%	0,00%	US$ 1,96 B	3,86%
LEN-B	13,47	1,25	9,26%	1,80%	US$ 28,40 B	6,49%
AFYA	10,04	1,57	15,60%	1,61%	US$ 1,31 B	20,60%
GNTX	15,05	2,32	15,40%	1,87%	US$ 5,64 B	15,39%
NWL	2.023,12	0,75	0,04%	5,79%	US$ 2,02 B	0,01%
HBI	16,94	14,34	84,68%	0,00%	US$ 2,39 B	3,88%
GRBK	8,11	1,55	19,10%	0,00%	US$ 2,78 B	15,85%

comparison of MEDS with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History MEDS

current DY: 125,16%

5-year average DY: 125,16%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	19/07/2024	24/07/2024	1,50000000
Dividends	18/03/2024	22/03/2024	8,00000000
Dividends	18/03/2024	22/03/2024	8,00000000
Dividends	18/03/2024	22/03/2024	8,00000000
Dividends	18/03/2024	22/03/2024	8,00000000
Dividends	18/03/2024	22/03/2024	8,00000000
Dividends	18/03/2024	22/03/2024	8,00000000
Dividends	18/03/2024	22/03/2024	8,00000000
Dividends	18/03/2024	22/03/2024	8,00000000
Dividends	18/03/2024	22/03/2024	8,00000000
Dividends	18/03/2024	22/03/2024	8,00000000
Dividends	18/03/2024	22/03/2024	8,00000000
Dividends	18/03/2024	22/03/2024	8,00000000
Dividends	18/03/2024	22/03/2024	8,00000000
Dividends	18/03/2024	22/03/2024	8,00000000
Dividends	18/03/2024	22/03/2024	8,00000000
Dividends	18/03/2024	22/03/2024	8,00000000
Dividends	18/03/2024	22/03/2024	8,00000000
Dividends	18/03/2024	22/03/2024	8,00000000
Dividends	18/03/2024	22/03/2024	8,00000000
Dividends	18/03/2024	22/03/2024	8,00000000

ABOUT THE COMPANY Trxade Group

Trxade Group Inc.

Average user rating I10

4.0 (1 people)

Estados Unidos

20 years

Foundation: 2005

2008

Year of debut on the stock exchange - 17 years

43

Employees

The Company Trxade Group Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 7,59 Milhões, having a net worth of $ 11,79 Milhões.

With a total of 43 employees, the company is listed in the sector of Consumer Discretionary Products and categorized in industry of Internet and Digital Marketing Retail.

In the last 12 months the Company had a revenue of $ 4,14 Milhões, which generated a loss in the amount of $ 16,54 Milhões.

As for its main indicators, the Company has a P/E ratio of 0,46, a P/BV ratio of 0,64 and in the last 12 months the dividend yield of MEDS was at 125,16%.

The Company is traded internationally through the ticker MEDS.

Market value

US$ 7,59 Milhões

Net worth

US$ 11,79 Milhões

US$ 11.790.000,00

Assets

US$ 14,85 Milhões

US$ 14.850.000,00

Total Number of Shares

1,00 Million

1.000.000

Average Daily Trading Volume

US$ 70,99 Thousand

US$ 70.986,04

Sector

Consumer Discretionary Products

Industry

Internet and Digital Marketing Retail

MEDS

MEDS revenue and profits

MEDS results

DRAG THE FRAME TO SEE MORE DATA

MEDS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

DHI - D. R. Horton

US$ 155,24 --18,42% (12M)

P/L

12,44

1,06%

ROE

15,06%

P/VP

1,87

LEN - Lennar

US$ 122,44 --32,68% (12M)

P/L

14,43

1,68%

ROE

9,26%

P/VP

1,34

LEN-B - Lennar

US$ 115,11 --31,80% (12M)

P/L

13,47

1,80%

ROE

9,26%

P/VP

1,25

GT - Goodyear Tire & Rubber

US$ 6,71 --19,93% (12M)

P/L

2,80

0,00%

ROE

13,20%

P/VP

0,37

DASH - DoorDash

US$ 272,61 80,06% (12M)

P/L

125,06

0,00%

ROE

10,13%

P/VP

12,66

LVS - Las Vegas Sands

US$ 49,03 --1,40% (12M)

P/L

21,58

1,91%

ROE

70,03%

P/VP

15,11

EBAY - eBay

US$ 90,87 37,96% (12M)

P/L

19,20

1,25%

ROE

45,99%

P/VP

8,83

IHG - InterContinental Hotels

US$ 120,34 8,39% (12M)

P/L

12,07

1,43%

ROE

-59,32%

P/VP

-7,16

DHI - D. R. Horton

US$ 155,24 --18,42% (12 M)

P/L

12,44

1,06%

ROE

15,06%

P/VP

1,87

LEN - Lennar

US$ 122,44 --32,68% (12 M)

P/L

14,43

1,68%

ROE

9,26%

P/VP

1,34

LEN-B - Lennar

US$ 115,11 --31,80% (12 M)

P/L

13,47

1,80%

ROE

9,26%

P/VP

1,25

GT - Goodyear Tire & Rubber

US$ 6,71 --19,93% (12 M)

P/L

2,80

0,00%

ROE

13,20%

P/VP

0,37

DASH - DoorDash

US$ 272,61 80,06% (12 M)

P/L

125,06

0,00%

ROE

10,13%

P/VP

12,66

LVS - Las Vegas Sands

US$ 49,03 --1,40% (12 M)

P/L

21,58

1,91%

ROE

70,03%

P/VP

15,11

EBAY - eBay

US$ 90,87 37,96% (12 M)

P/L

19,20

1,25%

ROE

45,99%

P/VP

8,83

IHG - InterContinental Hotels

US$ 120,34 8,39% (12 M)

P/L

12,07

1,43%

ROE

-59,32%

P/VP

-7,16

Frequently Asked Questions

What is the price of Trxade Group (MEDS) today?

The price of Trxade Group (MEDS) today is US$ 0,00, with a variation of 0% compared to the last year. The price of Trxade Group (MEDS) started the year trading around US$ 0,00 and today it is at US$ 0,00. Follow the real-time price chart, the historical price of Trxade Group (MEDS), and stock data from Ibovespa and international markets.

When does Trxade Group (MEDS) pay dividends?

Trxade Group (MEDS) não distribuiu dividendos no último ano.

Trxade Group (MEDS) is it worth it?

Currently, Trxade Group (MEDS) is priced at US$ 0,00, with a P/E of 0,46%, representing a deviation of 0,09% from its historical average P/E. In the last year, the stock showed a variation of 0% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 125,16%. The total shareholder return was 0,00%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of Trxade Group (MEDS)?

Investing in stocks of Trxade Group (MEDS) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of Trxade Group (MEDS) yield today?

The yield of Trxade Group (MEDS) was 0,00% in the last month, 0,00% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 125,16%.

If you wanted to buy 100 stocks of Trxade Group (MEDS) today, the total investment would be US$ 0,00, based on the current price of US$ 0,00.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 0,00
In 5 years: US$ 0,00
In 10 years: 0,00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

MEDS

Trxade Group Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of MEDS

check out the fundamentals of Trxade Group shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 125,16%

5-year average DY: 125,16%

type

date with

payment date

value

ABOUT THE COMPANY Trxade Group

Trxade Group Inc.

Estados Unidos

20 years

2008

43

PROFIT X PRICE MEDS

MEDS results

MEDS cash flow

evolution of assets - MEDS

MEDS balance sheet

DHI - D. R. Horton

LEN - Lennar

LEN-B - Lennar

GT - Goodyear Tire & Rubber

DASH - DoorDash

LVS - Las Vegas Sands

EBAY - eBay

IHG - InterContinental Hotels

DHI - D. R. Horton

LEN - Lennar

LEN-B - Lennar

GT - Goodyear Tire & Rubber

DASH - DoorDash

LVS - Las Vegas Sands

EBAY - eBay

IHG - InterContinental Hotels

Frequently Asked Questions